COVID-19 Vaccines

New research out of New York found the protection of the vaccine against infection in kids ages 5 to 11 dropped from 68% to 12%.

At this point, one thing about the pandemic is clear: The COVID-19 vaccines, even when followed by a booster, aren't going to stop the coronavirus.

Add more boosters? Redesign to anticipate new variants? Researchers are evaluating possibilities for improvement.

Experts at Penn say nurses can play a major role by offering access to and helping patients understand accurate health care information.

With protesters in clear retreat, the end of the three-week protest against the country’s COVID-19 restrictions and the government appeared to be in sight.

Restaurant and venue owners largely praised Philadelphia’s decision to immediately end the requirement to present proof-of-vaccination to dine indoors.

City officials unveiled a four-level tier system to help them determine when certain COVID-19 mitigation efforts may be lifted.

The firefighters union says up to 30% of its members could be suspended under the mandate.

The FDA’s surprise announcement Friday set the expected schedule for vaccine eligibility for the youngest Americans back several months.

The FDA reversed course and said it had become clear it needed to wait for data on how well that third shot works for this age group.

On Tuesday, the Health Resources and Services Administration is distributing $66.5 million to community groups working in 38 states and in Washington, D.C.

The governor says people need to protect themselves with the mask mandate for businesses ending Friday, and for schools on April 1.

Citing recent data from the CDC, officials in the Garden State will use all of their outreach strategies to promote boosters.

The first big hurdle was crossed when Pfizer shared its clinical trial data with the FDA. There are five more steps before this vulnerable population can be vaxxed.

The move could open the way for the very youngest Americans to start receiving shots by early March.